INCRETIN AND GLUCAGON SIGNALLING IN MASLD AND MASH: INTEGRATING METABOLIC PATHWAYS WITH DISEASE PROGRESSION

Descargar Publicación
Body Composition and Function in Patients with Obesity in Clinical Practice: Beyond the Body Mass Index AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update